Abbreviations Used in Chapter 14
| ACCORD | Action to Control Cardiovascular Risk in Diabetes |
| AF | atrial fibrillation |
| AHA | American Heart Association |
| AHI | apnea-hypopnea index |
| ARIC | Atherosclerosis Risk in Communities study |
| AHRQ | Agency for Healthcare Research and Quality |
| BASIC | Brain Attack Surveillance in Corpus Christi |
| BP | blood pressure |
| BRFSS | Behavioral Risk Factor Surveillance System |
| CDC | Centers for Disease Control and Prevention |
| CHD | coronary heart disease |
| CHS | Cardiovascular Health Study |
| CI | confidence interval |
| CLRD | chronic lower respiratory disease |
| CREST | Carotid Revascularization Endarterectomy versus Stenting Trial |
| CVD | cardiovascular disease |
| DM | diabetes mellitus |
| ED | emergency department |
| eGFR | estimated glomerular filtration rate |
| EMS | emergency medical services |
| FHS | Framingham Heart Study |
| FRS | Framingham Risk Score |
| FUTURE | Follow-up of TIA and Stroke Patients and Unelucidated Risk Factor Evaluation |
| GCNKSS | Greater Cincinnati/Northern Kentucky Stroke Study |
| GFR | glomerular filtration rate |
| GWTG | Get With The Guidelines |
| HBP | high blood pressure |
| HCUP | Healthcare Cost and Utilization Project |
| HD | heart disease |
| HDL | high-density lipoprotein |
| HF | heart failure |
| HR | hazard ratio |
| ICD-9 | International Classification of Diseases, 9th Revision |
| ICD-10 | International Classification of Diseases, 10th Revision |
| ICH | intracerebral hemorrhage |
| MEPS | Medical Expenditure Panel Survey |
| MI | myocardial infarction |
| NCHS | National Center for Health Statistics |
| NH | non-Hispanic |
| NHAMCS | National Hospital Ambulatory Medical Care Survey |
| NHANES | National Health and Nutrition Examination Survey |
| NHDS | National Hospital Discharge Survey |
| NHIS | National Health Interview Survey |
| NHLBI | National Heart, Lung, and Blood Institute |
| NINDS | National Institutes of Neurological Disorders and Stroke |
| NOMAS | Northern Manhattan Study |
| ONTARGET | Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial |
| OR | odds ratio |
| PA | physical activity |
| PAR | population attributable risk |
| REGARDS | Reasons for Geographic and Racial Differences in Stroke study |
| RR | relative risk |
| SAH | subarachnoid hemorrhage |
| SPS3 | Secondary Prevention of Small Subcortical Strokes |
| SBP | systolic blood pressure |
| SWITCH | Stroke With Transfusions Changing to Hydroxyurea |
| TIA | transient ischemic attack |
| tPA | tissue-type plasminogen activator |